PDS Biotechnology
PDSB
PDSB
53 hedge funds and large institutions have $139M invested in PDS Biotechnology in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+7
Holders Change %
+15.22%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
26
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
BNP Paribas Financial Markets
Paris,
France
| $5.74K | +$5.74K | +28 | New |
|
|
AIM
52
Advantage Investment Management
Cedar Rapids,
Iowa
| $5K | – | – | – |
|
53
Bank of America
Charlotte,
North Carolina
| $3K | +$3K | +15 | New |
|
|
DCM
54
DAFNA Capital Management
Los Angeles,
California
| – | -$633K | -3,459 | Closed |
|
|
TC
55
TFS Capital
West Chester,
Pennsylvania
| – | -$121K | -664 | Closed |
|
56
D.E. Shaw & Co
New York
| – | -$112K | -613 | Closed |
|
57
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$110K | -600 | Closed |
|
|
WPC
58
White Pine Capital
Bloomington,
Minnesota
| – | -$106K | -581 | Closed |
|